1 |
Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K, Yabuta K. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumor necrosis factoralpha and interleukin 6 in serum. Eur J Pediatr 1992;151: 44-7
DOI
ScienceOn
|
2 |
Maury CP, Salo E, Pelkonen P. Elevated circulating tumor necrosis factor- in patients with Kawasaki disease. J Lab Clin Med 1989;113:651-4
|
3 |
Fukuda S, Hashimoto N, Naritomi H, Nagata I, Nozaki K, Kondo S, et al. Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation 2000;101:2532-8
DOI
ScienceOn
|
4 |
Stoclet JC, Muller B, Andriantsitohaina R, Kleschyov A. Overproduction of nitric oxite in pathophysiology of blood vessels. Biochemistry 1998;63:826-32
|
5 |
Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum 1988; 41:1141-51
DOI
ScienceOn
|
6 |
Moncada S, Palmer RMJ, Higgs EA. Nitric oxide : physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42
|
7 |
Aeberhard EE, Henderson SA, Arabolos NS, Griscavage JM, Castro FE, Barrett CT, et al. Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem Biophys Res Commun 1995; 208:1053-9
DOI
ScienceOn
|
8 |
Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, et al. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988;48:247-51
DOI
ScienceOn
|
9 |
Geng Y, Hansson GK, Holme E. Interferon- and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 1992;71:2532-8
|
10 |
Johanning JM, Franklin DP, Han DC, Carey DJ, Elmore JR. Inhibition of inducible nitric oxide synthase limits nitric oxide production and experimental aneurysm expansion. J Vasc Surg 2001;33:579-86
DOI
ScienceOn
|
11 |
Suzuki A, Kamiya T, Arakaki Y, Kinoshita Y, Kimura K. Fate of coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 1994;74:822-4
DOI
ScienceOn
|
12 |
Ikemoto Y, Teraguchi M, Ono A, Kino M, Yoshimura K, Kobayashi Y. Serial changes of plasma nitrate in the acute phase of Kawasaki disease. Pediatr Int 2003;45:421-5
DOI
ScienceOn
|
13 |
Cuttica RJ. Vasculitis, Kawasaki disease and pseudovasculitis. Curr Opin Rheumatol 1997;9:448-57
DOI
PUBMED
ScienceOn
|
14 |
Kato H, Sugiyama T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. Circulation 1997;94: 1379-85
|
15 |
Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxy radical production by peroxynitirite : implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-4
|
16 |
Wang CL, Wu YT, Lee CJ, Liu HC, Huang LT, Yang KD. Decreased nitric oxide production after intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 2002;141:560-5
DOI
ScienceOn
|
17 |
Sriskandan S, Evans TJ, Cohen J. Bacterial superantigeninduced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFN-gamma. J Immunol 1996;156:2430-5
|
18 |
Schussler O, Lantoine F, Devynck MA, Glotz D, David- Dufilho M. Human immunoglobulins inhibit thrombin-induced movements and nitric oxide production on endothelial cells. J Biol Chem 1996;27:26473-6
|
19 |
Tsukahara H, Kikuchi K, Matsuda M, Saito M, Hata I, Tsuchida S, et al. Endogenous nitric oxide production in Kawasaki disease. Scand J Clin Lab Invest 1997;57:43-7
DOI
ScienceOn
|
20 |
Osorio JC, Xu X, Vogel T, Ochoa M, Laycock S, Hintze TH. Plasma nitrate accumulation during the development of pacing-induced dilated cardiac myopathy in conscious dogs is due to renal impairment. Nitric Oxide 2001;5:7-17
DOI
ScienceOn
|
21 |
Takahashi M. Kawasaki syndrome. In : Allen HD, Clark EB, editors. Moss and Adams' Heart Disease in Infants, Children and Adolescents. 6th ed. Philadelphia : Lippincott, Willams & Wilkins, 2001:1216-25
|
22 |
Lee R, Park SH, Kim YJ, Kim SY, Kim HH, Lee WB. Comparision of cytokine expressions among Kawasaki disease and its symptom-related disease. Korean J Pediatr 2004;27:567-73
|
23 |
Iizuka T, Oishi K, Sasaki M, Hatanaka Y, Minatogawa Y, Uemura S, et al. Nitric oxide and aneurysm formation in Kawasaki disease. Acta Paediatr 1997;86:470-3
DOI
ScienceOn
|
24 |
Fujiwara T, Fujiwara H, Nakano H. Pathological features of coronary arteries in children with Kawasaki disease in which coronary arterial aneurysm was absent at autopsy. Quantitative analysis. Circulation 1988;78:345-50
DOI
ScienceOn
|
25 |
Kroncke KD, Fehsel K, Kolb-Bachofen V. Inducible nitric oxide synthase in human disease. Clin Exp Immunol 1998; 113:147-56
DOI
PUBMED
|
26 |
Takahashi H, Nakanishi T, Nishimura M, Tanaka H, Yoshimura M. Measurements of serum levels of nitrate ions in men and women : implications of endothelium-derived relaxing factor in blood pressure regulation and atherosclerosis. J Cardiovasc Pharmacol 1992;20:S214-6
|
27 |
Yu X, Hirono KI, Ichida F, Uese KI, Rul C, Watanabe S. Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease. Pediatr Res 2004;55;688-94
DOI
ScienceOn
|